D.E. Shaw & Co
DMIIU

D.E. Shaw & Co’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

D.E. Shaw & Co’s Portfolio DMIIU Stock Details DMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000,000
Closed -$9.95M – 5140
2025
Q3 		$9.95M Buy
+1,000,000
New +$9.97M 0.01% 1696

Other funds holding DMIIU

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SCM
Steadfast Capital Management New York $3.26B AUM 36.54% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

D.E. Shaw & Co's DMIIU Position: Q4 2025 in Review

D.E. Shaw & Co sold out of Drugs Made In America Acquisition II Corp Unit (DMIIU) in Q4 2025, closing a stake of 1,000,000 shares — an estimated $9.95M sold.

D.E. Shaw & Co first reported a position in DMIIU in Q3 2025 and held it in 1 quarter. The position peaked at $9.95M in Q3 2025. 30 funds tracked by Wall St. Rank hold DMIIU as of Q4 2025.

  • D.E. Shaw & Co reported no remaining Drugs Made In America Acquisition II Corp Unit position as of Q4 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,000,000 Drugs Made In America Acquisition II Corp Unit shares in Q4 2025, an estimated $9.95M.
  • D.E. Shaw & Co first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and held it in 1 quarter.
  • D.E. Shaw & Co's Drugs Made In America Acquisition II Corp Unit position peaked at $9.95M in Q3 2025.
  • 30 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.